Case Reports


doi: 10.1002/ehf2.13003.


Online ahead of print.

Affiliations

Item in Clipboard

Case Reports

Tiziana Attisano et al.


ESC Heart Fail.


.

Abstract

An 86-year-old man affected by severe aortic stenosis (AS) was referred to our institution owing to decompensated heart failure. Three months before, the patient was scheduled for transcatheter aortic valve implantation (TAVI), which was postponed owing to the coronavirus disease 2019 (COVID-19) outbreak. Owing to COVID-19 suspicion, he underwent nasopharyngeal swab and was temporarily isolated. However, the rapid deterioration of clinical and haemodynamic conditions prompted us to perform balloon aortic valvuloplasty (BAV) as bridge to TAVI. The patient’s haemodynamics improved; and the next day, the reverse transcriptase-polymerase chain reaction for COVID-19 was negative. At Day 5, he underwent TAVI procedure. Subsequent clinical course was uneventful. During COVID-19 pandemic, the deferral of TAVI procedure should be assessed on a case-by-case basis to avoid delay in patients at high risk for adverse events. BAV may be an option when TAVI is temporarily contraindicated such as in AS patients suspected for COVID-19.


Keywords:

Aortic stenosis; Balloon aortic valvuloplasty; COVID-19; Case report; Novel coronavirus; SARS-CoV-2; Transcatheter aortic valve implantation.

Similar articles

References

    1. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P, Leipsic J, Hahn RT, Blanke P, Williams MR, McCabe J, Brown DL, Babaliaros V, Goldman S, Szeto WY, Genereux P, Pershad A, Pocock SJ, Alu MC, Webb JG, Smith CR, PARTNER 3 Investigators. PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380: 1695-1705.

    1. Ribera A, Slof J, Ferreira-González I, Serra V, García-Del Blanco B, Cascant P, Andrea R, Falces C, Gutiérrez E, Del Valle-Fernández R, Morís-de laTassa C, Mota P, Oteo JF, Tornos P, García-Dorado D. The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement. Eur J Health Econ 2018; 19: 945-956.

    1. Elbaz-Greener G, Yarranton B, Qiu F, Wood DA, Webb JG, Fremes SE, Radhakrishnan S, Wijeysundera HC. Association between wait time for transcatheter aortic valve replacement and early postprocedural outcomes. J Am Heart Assoc 2019; 8: e010407.

    1. Kolte D, Khera S, Vemulapalli S, Dai D, Heo S, Goldsweig AM, Aronow HD, Elmariah S, Inglessis I, Palacios IF, Thourani VH, Sharaf BL, Gordon PC, Abbott JD. Outcomes following urgent/emergent transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018; 11: 1175-1185.

    1. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino FF, Rigattieri S, Limbruno U, Mauro C, La Manna A, Castiglioni B, Longoni M, Berti S, Greco F, Musumeci G, Esposito G, GISE. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv 2020:1-5, https://doi.org/10.1002/ccd.28888